Aurobindo Pharma's subsidiary, CuraTeQ Biologics got the green signal for the oncology biosimilar Bevqolva. CuraTeQ Biologics ...

Thousands of Memorial Sloan Kettering cancer patients could lose access to treatments in 2025 because of a contract fight ...

Chronic constipation, often dismissed as a minor issue, can sometimes signal serious underlying conditions like colon, rectal ...

This week's health news featured pivotal developments in pharmaceutical trials. GSK's cancer drug combo showed promising ...

New Castle County police officers, and members of Fraternal Order of Police Lodge #5, went above and beyond the call of duty ...

A diet low in omega-6 and enriched with omega-3 fatty acids and fish oil for prostate cancer patients on active surveillance ...

Dr. Patrick Hwu, CEO of Moffitt Cancer Center, shares insights on the Speros campus, advanced cancer treatments and ...

Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all. | Merck's and GSK's similar overall survival setbacks ...

First approved in 2021, Jemperli has now become a cornerstone of GSK’s cancer business, earning more than $160 million in the ...

As she turns 70, Chris Evert opens up about her journey, her legacy in tennis, and the personal milestones that continue to define her life.

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it. The symptoms ...